Integromics´ Real-Time StatMiner Chosen by Genzyme Corp. for Use In qPCR Analysis
News Mar 31, 2008
IntegromicsTM, a provider of data management/integration and analysis solutions for Life Sciences companies, has announced that Genzyme Corporation, one of the world’s foremost biotechnology companies, has licensed Real-Time StatMiner for their nucleic acids analysis. Analysts in Functional Genomics stated that using StatMiner was far faster than previous manual Excel methods, and its guided analytics eliminated the possibility of typographical errors, thereby improving the overall quality of data analysis.
Integromics’ Real-Time StatMinerTM is a high-performance application specifically designed for the new era of quantitative Applied Biosystems real-time PCR instrumentation and TaqMan Assays. Real-Time StatMiner is a plug-in for Spotfire DecisionSite powered with powerful statistics of Bioconductor.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.